
Sign up to save your podcasts
Or


In this interview, Gerald V. Naccarelli and Stephen D. Wiviott discuss the DECLARE-TIMI 58 (Dapagliflozin Effect on Cardiovascular Events–Thrombolysis in Myocardial Infarction 58) trial.
By American College of Cardiology3.8
5454 ratings
In this interview, Gerald V. Naccarelli and Stephen D. Wiviott discuss the DECLARE-TIMI 58 (Dapagliflozin Effect on Cardiovascular Events–Thrombolysis in Myocardial Infarction 58) trial.

139 Listeners

319 Listeners

498 Listeners

169 Listeners

884 Listeners

291 Listeners

140 Listeners

1,154 Listeners

40 Listeners

195 Listeners

91 Listeners

363 Listeners

429 Listeners

371 Listeners

32 Listeners